Skip to main content
. 2021 Aug 15;61(1):413–428. doi: 10.1007/s00394-021-02654-5

Fig. 6.

Fig. 6

Increasing levels of acetate, propionate, butyrate, and total SCFA observed in a SHIME® simulation of the proximal and distal colon following a 3-week period of in vitro treatment with Cereboost®. *Indicates significant change in SCFA metabolic activity during weeks 1, 2, and 3 of treatment compared with the control period, error bars represent mean standard deviation